Capability Building

We are experts at building industry-leading market access capabilities by designing and running bespoke in-house training programmes

Exceptional performance
in market access

We can help train your market access teams to excel in their day-to-day work.

Market access leaders have a responsibility to ensure that innovative medicines in their company pipeline reach patients as quickly as possible. They need to know what information is needed to de-risk critical investment decisions from a market access perspective and shape the development plan accordingly. They require an in-depth understanding of payer evidence requirements in different countries, how to develop pricing strategies, how to design robust RWE studies, how to develop a PRO strategy, what key cost generating events will likely drive a QALY calculation, what endpoints should be captured in the trial, how long should patients be followed-up etc. The list is endless. They also need to know how the market access strategy fits into the broader development strategy, and what trade-offs and compromises can be made, and those that can’t.

$375bnexpected spending total on cancer medicines by 2027

5%global increase number of treated patients over the past five years

2,000oncology products currently under development

a consultancy you can trust

we are  
industry experts

we are
dedicated

we are
patient-centric

a wealth of life science
knowledge and expertise

Oncology Access Solutions Ltd is led and founded by Dr Clare Hague – a highly experienced health economist and health services researcher with a strong industry and academic background.

With over 18 years of industry experience with large, mid-sized and start-up biotech companies, we Clare is a seasoned and knowledgeable independent consultant able to provide a discreet and dedicated service.

Learn more